NextCell Pharma AB (OSTO:NXTCL) Total Stockholders Equity : kr47.02 Mil (As of May. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Total Stockholders Equity?

NextCell Pharma AB's Total Stockholders Equity for the quarter that ended in May. 2024 was kr47.02 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. NextCell Pharma AB's Book Value per Share for the quarter that ended in May. 2024 was kr1.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. NextCell Pharma AB's Debt-to-Equity for the quarter that ended in May. 2024 was 0.00.

NextCell Pharma AB Total Stockholders Equity Historical Data

The historical data trend for NextCell Pharma AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Total Stockholders Equity Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Total Stockholders Equity

Get a 7-Day Free Trial

22.96

26.22

150.09

115.54

75.73

NextCell Pharma AB Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Total Stockholders Equity	Get a 7-Day Free Trial															84.30	75.73	65.93	55.84	47.02

NextCell Pharma AB (OSTO:NXTCL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

NextCell Pharma AB's Book Value per Share for the quarter that ended in May. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(47.017	-	0)	/	43.5248
	=	1.08

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

NextCell Pharma AB's Debt-to-Equity for the quarter that ended in May. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	47.017
	=	0.00

NextCell Pharma AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines